U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Name Type Language
H-gamma1 heavy chain humanized (1-447) [VH (Homo sapiens IGHV3-73*01 (86.9%) -(IGHD) -IGHJ1*01 (100%), CDR-IMGT [8.10.8] (26-33.51-60.99-106)) (1-117) -Homo sapiens IGHG1*01, G1m17,1 CH1 K120, CH3 D12, L14, 6-G1v3-1 A1.2, A1 (CH1 K120 (214) (118-215), hi
Preferred Name English
Plozalizumab Plevistinag
Common Name English
Immunoglobulin G1, anti-(human CC chemokine receptor CCR2) (human-Mus musculus monoclonal 1D9 ?1-chain), disulfide with human-Mus musculus monoclonal 1D9 ?-chain, dimer, thioether with [P(R)]-2?-deoxy-2?-fluoro-5?-O-[(R)-hydroxymercaptophosphinyl]-N-[2-[
Common Name English
immunoglobulin G1-kappa, anti-[Homo sapiens CCR2 (chemokine (C-C motif) receptor 2, C-C chemokine receptor 2, CC-CKR-2, CKR-2, monocyte chemoattractant protein 1 receptor, MCP-1-R, CD192)], humanized monoclonal antibody, conjugated, on an average of 3.8-
Common Name English
plozalizumab plevistinag [INN]
Common Name English
Code System Code Type Description
CAS
2983832-01-3
Created by admin on Wed Apr 02 12:40:06 GMT 2025 , Edited by admin on Wed Apr 02 12:40:06 GMT 2025
PRIMARY
INN
13431
Created by admin on Wed Apr 02 12:40:06 GMT 2025 , Edited by admin on Wed Apr 02 12:40:06 GMT 2025
PRIMARY
FDA UNII
P5H59ZL4XA
Created by admin on Wed Apr 02 12:40:06 GMT 2025 , Edited by admin on Wed Apr 02 12:40:06 GMT 2025
PRIMARY